Skip to main content
Top
Gepubliceerd in: Neuropraxis 5/2018

10-09-2018 | Artikel

Het verband tussen cognitieve functies en vasculaire risicofactoren van jongmiddelbare tot oudere leeftijd

Auteurs: Marlise E. A. van Eersel, Hanneke Joosten, Joris P. J. Slaets, Gerbrand J. Izaks

Gepubliceerd in: Neuropraxis | Uitgave 5/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Er is nog geen behandeling om mensen te genezen van dementie. Daarom wordt er veel onderzoek gedaan naar mogelijkheden om dementie te voorkomen. Een van de aandachtspunten binnen het preventieve onderzoek is de behandeling van vasculaire risicofactoren, zoals hypertensie, hypercholesterolemie en diabetes mellitus, en het stoppen met roken. Deze vasculaire risicofactoren veroorzaken aderverkalking, wat bijdraagt aan neurodegeneratieve veranderingen die ten grondslag liggen aan dementie. Het algemene doel van ons onderzoek was om het verband tussen cognitieve functies en vasculaire risicofactoren vanaf jongmiddelbare tot oudere leeftijd te onderzoeken. Daarnaast onderzochten we of er een verband bestaat tussen de verandering in cognitieve functies en de medicamenteuze behandeling van vasculaire risicofactoren. Samenvattend hebben we gevonden dat er een negatief verband is tussen de cognitieve functies en de vasculaire risicofactoren. Hoe hoger het vasculair risico, hoe slechter de cognitieve functies. Dit verband is het sterkst aanwezig op jongmiddelbare leeftijd. Dit suggereert dat er zo vroeg mogelijk gestart zou moeten worden met behandeling van vasculaire risicofactoren om effectief te zijn in het voorkomen van achteruitgang van de cognitieve functies. In dit onderzoek kon echter niet worden bevestigd dat vroege medicamenteuze behandeling van vasculaire risicofactoren de cognitieve functies verbetert.
Literatuur
1.
go back to reference Alzheimer’s Disease International. World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Londen: Alzheimer’s Disease International; 2015. Alzheimer’s Disease International. World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Londen: Alzheimer’s Disease International; 2015.
3.
go back to reference Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol. 2015;12(5):267–77.CrossRefPubMed Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol. 2015;12(5):267–77.CrossRefPubMed
4.
go back to reference Rodrigue KM, Rieck JR, Kennedy KM, Devous MDS, Diaz-Arrastia R, Park DC. Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 2013;70(5):600–6.CrossRefPubMedPubMedCentral Rodrigue KM, Rieck JR, Kennedy KM, Devous MDS, Diaz-Arrastia R, Park DC. Risk factors for beta-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 2013;70(5):600–6.CrossRefPubMedPubMedCentral
5.
go back to reference Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17(3):259–73.CrossRefPubMed Swan GE, Lessov-Schlaggar CN. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev. 2007;17(3):259–73.CrossRefPubMed
6.
go back to reference Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–9.CrossRefPubMed Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–9.CrossRefPubMed
7.
go back to reference Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis. 2008;101(3):181–9.CrossRefPubMed Duron E, Hanon O. Hypertension, cognitive decline and dementia. Arch Cardiovasc Dis. 2008;101(3):181–9.CrossRefPubMed
8.
go back to reference Berg E van den, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792(5):470–81.CrossRefPubMed Berg E van den, Kloppenborg RP, Kessels RP, Kappelle LJ, Biessels GJ. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792(5):470–81.CrossRefPubMed
9.
go back to reference Ligthart SA, Moll van Charante EP, Gool WA Van, Richard E. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag. 2010;6:775–85.CrossRefPubMedPubMedCentral Ligthart SA, Moll van Charante EP, Gool WA Van, Richard E. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag. 2010;6:775–85.CrossRefPubMedPubMedCentral
10.
go back to reference Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–92.CrossRefPubMedPubMedCentral Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280–92.CrossRefPubMedPubMedCentral
11.
go back to reference Eersel MEA van. The association of cognitive performance with vascular risk factors across the adult life span. Groningen: Rijksuniversiteit Groningen; 2018. Eersel MEA van. The association of cognitive performance with vascular risk factors across the adult life span. Groningen: Rijksuniversiteit Groningen; 2018.
12.
go back to reference Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, et al. Microalbuminuria and risk of venous thromboembolism. JAMA. 2009;301(17):1790–7.CrossRefPubMed Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, et al. Microalbuminuria and risk of venous thromboembolism. JAMA. 2009;301(17):1790–7.CrossRefPubMed
13.
go back to reference Lambers Heerspink HJ, Brantsma AH, Zeeuw D de, Bakker SJ, Jong PE de, Gansevoort RT, et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008;168(8):897–905.CrossRefPubMed Lambers Heerspink HJ, Brantsma AH, Zeeuw D de, Bakker SJ, Jong PE de, Gansevoort RT, et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008;168(8):897–905.CrossRefPubMed
14.
go back to reference Ruff R. Ruff Figural Fluency Test: professional manual. Lutz: Psychological Assessment Resources; 1996. Ruff R. Ruff Figural Fluency Test: professional manual. Lutz: Psychological Assessment Resources; 1996.
15.
go back to reference Lindeboom J, Schmand B. Visual Association Test. Manual. Leiden: PITS BV; 2003. Lindeboom J, Schmand B. Visual Association Test. Manual. Leiden: PITS BV; 2003.
16.
go back to reference Ruff R, Light R, Evans R. The Ruff Figural Fluency Test: a normative study with adults. Dev Neuropsychol. 1987;3:37–51.CrossRef Ruff R, Light R, Evans R. The Ruff Figural Fluency Test: a normative study with adults. Dev Neuropsychol. 1987;3:37–51.CrossRef
17.
go back to reference Izaks GJ, Joosten H, Koerts J, Gansevoort RT, Slaets JP. Reference data for the Ruff Figural Fluency Test stratified by age and educational level. PLoS ONE. 2011;6(2):e17045.CrossRefPubMedPubMedCentral Izaks GJ, Joosten H, Koerts J, Gansevoort RT, Slaets JP. Reference data for the Ruff Figural Fluency Test stratified by age and educational level. PLoS ONE. 2011;6(2):e17045.CrossRefPubMedPubMedCentral
18.
go back to reference D’Agostino RBS, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.CrossRefPubMed D’Agostino RBS, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.CrossRefPubMed
19.
go back to reference Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791–8.CrossRefPubMed Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791–8.CrossRefPubMed
20.
go back to reference Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):285–92.CrossRefPubMed Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res. 2013;13(3):285–92.CrossRefPubMed
21.
go back to reference Joosten H, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44(6):1543–9.CrossRefPubMed Joosten H, Eersel ME van, Gansevoort RT, Bilo HJ, Slaets JP, Izaks GJ. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects. Stroke. 2013;44(6):1543–9.CrossRefPubMed
22.
go back to reference Eersel ME van, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS ONE. 2013;8(12):e82991.CrossRefPubMedPubMedCentral Eersel ME van, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS ONE. 2013;8(12):e82991.CrossRefPubMedPubMedCentral
23.
go back to reference Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116–24.CrossRefPubMed Wu YT, Fratiglioni L, Matthews FE, Lobo A, Breteler MM, Skoog I, et al. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurol. 2016;15(1):116–24.CrossRefPubMed
24.
go back to reference Muller M, Sigurdsson S, Kjartansson O, Jonsson PV, Garcia M, Bonsdorff MB von, et al. Birth size and brain function 75 years later. Pediatrics. 2014;134(4):761–70.CrossRefPubMedPubMedCentral Muller M, Sigurdsson S, Kjartansson O, Jonsson PV, Garcia M, Bonsdorff MB von, et al. Birth size and brain function 75 years later. Pediatrics. 2014;134(4):761–70.CrossRefPubMedPubMedCentral
25.
go back to reference Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616–22.CrossRefPubMed Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291(21):2616–22.CrossRefPubMed
26.
go back to reference Denton FT, Spencer BG. Chronic health conditions: changing prevalence in an aging population and some implications for the delivery of health care services. Can J Aging. 2010;29(1):11–21.CrossRefPubMed Denton FT, Spencer BG. Chronic health conditions: changing prevalence in an aging population and some implications for the delivery of health care services. Can J Aging. 2010;29(1):11–21.CrossRefPubMed
27.
go back to reference Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med. 2007;120(3 Suppl 1):S12–S8.CrossRefPubMed Rader DJ. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Am J Med. 2007;120(3 Suppl 1):S12–S8.CrossRefPubMed
28.
go back to reference Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–9.CrossRefPubMed Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815–9.CrossRefPubMed
29.
go back to reference Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81.CrossRefPubMed Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287(19):2570–81.CrossRefPubMed
30.
go back to reference Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000;23(11):542–9.CrossRefPubMed Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000;23(11):542–9.CrossRefPubMed
31.
go back to reference Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease. J Alzheimers Dis. 2009;16(4):741–61.CrossRefPubMed Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer’s disease. J Alzheimers Dis. 2009;16(4):741–61.CrossRefPubMed
32.
go back to reference Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6(3):275–84.CrossRefPubMed Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell. 2007;6(3):275–84.CrossRefPubMed
33.
go back to reference Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.CrossRefPubMed Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.CrossRefPubMed
34.
go back to reference Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487–99.CrossRefPubMed Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487–99.CrossRefPubMed
35.
go back to reference Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer’s disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32(3):531–40.CrossRefPubMed Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer’s disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32(3):531–40.CrossRefPubMed
36.
go back to reference Richard E, Andrieu S, Solomon A, Mangialasche F, Ahtiluoto S, Moll van Charante EP, et al. Methodological challenges in designing dementia prevention trials—the European Dementia Prevention Initiative (EDPI). J Neurol Sci. 2012;322(1–2):64–70.CrossRefPubMed Richard E, Andrieu S, Solomon A, Mangialasche F, Ahtiluoto S, Moll van Charante EP, et al. Methodological challenges in designing dementia prevention trials—the European Dementia Prevention Initiative (EDPI). J Neurol Sci. 2012;322(1–2):64–70.CrossRefPubMed
37.
go back to reference Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis. 2009;16(2):235–70.CrossRefPubMed Andrieu S, Coley N, Aisen P, Carrillo MC, DeKosky S, Durga J, et al. Methodological issues in primary prevention trials for neurodegenerative dementia. J Alzheimers Dis. 2009;16(2):235–70.CrossRefPubMed
38.
go back to reference Euser SM, Bemmel T van, Schram MT, Gussekloo J, Hofman A, Westendorp RGJ, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 2009;57(7):1232–7.CrossRefPubMed Euser SM, Bemmel T van, Schram MT, Gussekloo J, Hofman A, Westendorp RGJ, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 2009;57(7):1232–7.CrossRefPubMed
39.
go back to reference Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res. 2007;19(1):41–7.CrossRefPubMed Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res. 2007;19(1):41–7.CrossRefPubMed
41.
go back to reference Strozyk D, Dickson DW, Lipton RB, Katz M, Derby CA, Lee S, et al. Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging. 2010;31(10):1710–20.CrossRefPubMed Strozyk D, Dickson DW, Lipton RB, Katz M, Derby CA, Lee S, et al. Contribution of vascular pathology to the clinical expression of dementia. Neurobiol Aging. 2010;31(10):1710–20.CrossRefPubMed
42.
Metagegevens
Titel
Het verband tussen cognitieve functies en vasculaire risicofactoren van jongmiddelbare tot oudere leeftijd
Auteurs
Marlise E. A. van Eersel
Hanneke Joosten
Joris P. J. Slaets
Gerbrand J. Izaks
Publicatiedatum
10-09-2018
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Neuropraxis / Uitgave 5/2018
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI
https://doi.org/10.1007/s12474-018-00200-4

Andere artikelen Uitgave 5/2018

Neuropraxis 5/2018 Naar de uitgave